版本:
中国

BRIEF-Actinium Pharmaceuticals says iomab-b late-stage trial enrollment accelerates

June 15 Actinium Pharmaceuticals Inc-

* Actinium Pharmaceuticals Inc says iomab-b phase 3 sierra trial enrollment is accelerating as number of clinical trial sites increase

* Actinium Pharmaceuticals Inc says actimab-a phase 2 trial remains on target to yield interim data in second half of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐